Kong Z - Search Results

1

Quantitative Features From CHO PET Distinguish the WHO Grades of Primary Diffuse Glioma.

Kong Z, Jiang C, Liu D, Chen W, Ma W, Cheng X, Wang Y. Kong Z, et al. Clin Nucl Med. 2021 Feb 1;46(2):103-110. doi: 10.1097/RLU.0000000000003406. Clin Nucl Med. 2021. PMID: 33208625

2

Vaccination in the immunotherapy of glioblastoma.

Kong Z, Wang Y, Ma W. Kong Z, et al. Hum Vaccin Immunother. 2018 Feb 1;14(2):255-268. doi: 10.1080/21645515.2017.1388481. Epub 2017 Dec 11. Hum Vaccin Immunother. 2018. PMID: 29087782 Free PMC article. Review.

3

Central Nervous System Germ Cell Tumors: A Review of the Literature.

Kong Z, Wang Y, Dai C, Yao Y, Ma W, Wang Y. Kong Z, et al. J Child Neurol. 2018 Aug;33(9):610-620. doi: 10.1177/0883073818772470. Epub 2018 May 30. J Child Neurol. 2018. PMID: 29848146 Review.

4

Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.

Kong Z, Yan C, Zhu R, Wang J, Wang Y, Wang Y, Wang R, Feng F, Ma W. Kong Z, et al. Neuroimage Clin. 2018 Jul 5;20:51-60. doi: 10.1016/j.nicl.2018.07.001. eCollection 2018. Neuroimage Clin. 2018. PMID: 30069427 Free PMC article. Review.

5

Quantitative and Visual Characteristics of Primary Central Nervous System Lymphoma on ¹⁸F-FDG-PET.

Liu D, Kong Z, Wang Y, Chen W, Wang Y, Chen W, Liu L, Dang Y, Ma W, Wang Y, Cheng X. Liu D, et al. Among authors: kong z. Interdiscip Sci. 2019 Jun;11(2):300-306. doi: 10.1007/s12539-019-00333-y. Epub 2019 Jul 1. Interdiscip Sci. 2019. PMID: 31264053

6

Radiomics signature based on FDG-PET predicts proliferative activity in primary glioma.

Kong Z, Li J, Liu Z, Liu Z, Zhao D, Cheng X, Li L, Lin Y, Wang Y, Tian J, Ma W. Kong Z, et al. Clin Radiol. 2019 Oct;74(10):815.e15-815.e23. doi: 10.1016/j.crad.2019.06.019. Epub 2019 Jul 31. Clin Radiol. 2019. PMID: 31376917

7

¹⁸F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma.

Kong Z, Lin Y, Jiang C, Li L, Liu Z, Wang Y, Dai C, Liu D, Qin X, Wang Y, Liu Z, Cheng X, Tian J, Ma W. Kong Z, et al. Cancer Imaging. 2019 Aug 19;19(1):58. doi: 10.1186/s40644-019-0246-0. Cancer Imaging. 2019. PMID: 31426864 Free PMC article.

8

¹⁸F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma.

Kong Z, Jiang C, Zhu R, Feng S, Wang Y, Li J, Chen W, Liu P, Zhao D, Ma W, Wang Y, Cheng X. Kong Z, et al. Neuroimage Clin. 2019;23:101912. doi: 10.1016/j.nicl.2019.101912. Epub 2019 Jun 27. Neuroimage Clin. 2019. PMID: 31491820 Free PMC article.

9

FDG PET/CT Image for a Rosai-Dorfman Disease With Pituitary and Bone Involvement in a Pediatric Patient.

Kong Z, Wang Y, Ma W, Cheng X. Kong Z, et al. Clin Nucl Med. 2019 Nov;44(11):873-875. doi: 10.1097/RLU.0000000000002776. Clin Nucl Med. 2019. PMID: 31584488

10

Progress and Prospects of Recurrent Glioma: A Recent Scientometric Analysis of the Web of Science in 2019.

Chen W, Lei C, Liu P, Liu Y, Guo X, Kong Z, Wang Y, Dai C, Wang Y, Ma W, Wang Y. Chen W, et al. Among authors: kong z. World Neurosurg. 2020 Feb;134:e387-e399. doi: 10.1016/j.wneu.2019.10.078. Epub 2019 Oct 19. World Neurosurg. 2020. PMID: 31639500 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,238 results

Search Page

Filters